#Switzerland #Medical Devices #Healthcare Holding #Baar #Effectum CH-Rep

Healthcare Holding Schweiz Expands Its Footprint in Medical Technology

Healthcare Holding Schweiz AG, a prominent player in the Swiss medical technology sector, has recently finalized the acquisition of Effectum CH-Rep AG. This strategic move is anticipated to bolster the company's capabilities in providing comprehensive services to medical device manufacturers operating in Switzerland.

Significance of the Acquisition

This acquisition, announced on March 17, 2025, is not just a transfer of ownership; it's a pivotal carve-out which consolidates various regulatory services offered by Effectum Medical AG. The Medical Devices Ordinance (MedDO SR 812.213), established in May 2021, mandates that any foreign manufacturer wishing to distribute medical devices in Switzerland must appoint a Swiss Authorized Representative (CH-REP). By integrating Effectum CH-Rep into its portfolio, Healthcare Holding Schweiz positions itself as an all-encompassing partner for both domestic and international medical technology firms, streamlining compliance and operational processes.

Expanding Service Offerings

Fabio Fagagnini, CEO of Healthcare Holding Schweiz, expressed his enthusiasm following the acquisition, stating, "With Effectum CH-Rep, we are enhancing our service offerings by incorporating the role of Swiss Authorized Representative. This addition enables our team to concentrate on delivering innovative products and unparalleled customer service while assuring all regulatory obligations are professionally addressed."

Kim Züger, who will lead Quality Management Regulatory Affairs at Effectum CH-Rep, highlighted that regulatory compliance remains a top priority. She emphasized the new entity's mission to offer regulatory services not only to Healthcare Holding's suppliers but also to other manufacturers, reinforcing the promise of high-quality standards and professionalism.

Michael Eggimann, a board member of Effectum Medical AG involved in the sale, voiced his confidence in the transition, indicating that it would allow the prior entity to focus on developing their core offerings, including a unique plug-and-play quality management system, while maintaining a strong partnership with Effectum CH-Rep.

About Effectum CH-Rep AG

Based in Olten, Effectum CH-Rep AG serves as a Swiss representative for foreign manufacturers, ensuring compliance with Swiss regulations. The company plays a crucial role in facilitating access to the Swiss market, managing regulatory compliance, ensuring technical documentation is accessible, and addressing any incidents or complaints.

About Healthcare Holding Schweiz AG

As a leading technology-driven entity in the medical technology landscape, Healthcare Holding Schweiz AG pursues an ambitious growth agenda through acquisitions and strategic partnerships. The company is committed to employing technology to enhance safety and efficiency across its operations. Healthcare Holding Schweiz not only aims to set new benchmarks within the industry but also provides its staff with ample opportunities for professional growth. The management team holds equity interests in the company, fostering a community of entrepreneurial leadership.

The Role of Winterberg Group AG

The acquisition is also supported by Winterberg Group AG, which operates as an independent family office focused predominantly on small to medium enterprises in the DACH region, while selectively considering startups and real estate ventures. Winterberg Advisory GmbH is notably recognized for managing various private equity funds, contributing to significant growth opportunities for Healthcare Holding Schweiz.

In conclusion, the acquisition of Effectum CH-Rep by Healthcare Holding Schweiz marks a transformative step in the medical device industry, ensuring robust compliance and enhancing service offerings within the Swiss market. As the medical technology landscape continues to evolve, this consolidation promises to deliver increased innovation and improved compliance standards for manufacturers operating in this crucial market.